ClinicalTrials.gg
CompletedNCT07765641Updated Aug 20, 2026

Interactive Demonstration-Based Cyber Health Education in High School Students

An interventional study of Interactive Demonstration-Based Cyber Health Education in Digital Health Literacy and Information Security Awareness, sponsored by Zeynep Yaztürk. Completed at 1 site in Turkey (Türkiye). Open to participants aged 15 Years to 19 Years. Per ClinicalTrials.gov, last updated 2026-08-20.

Sponsored by Zeynep Yaztürk · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Apr 2026, registered Aug 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
113
Allocation
Randomized
Ages
15 Years to 19 Years
Sex
All
01

Study summary

This randomized controlled trial evaluated the effect of an interactive demonstration-based cyber health education intervention on digital health literacy and information security awareness among high school students. Two public high schools were randomly assigned to the intervention and control groups. Students in the intervention group received a three-week education program consisting of one 30-40-minute session per week. The program included interactive presentations, demonstrations, scenario-based activities, group discussions, and question-and-answer sessions focusing on digital health literacy and information security. Students in the control group continued their routine school education without receiving the intervention during the study period. Digital health literacy and information security awareness were assessed at baseline, immediately after the intervention, and at a four-week follow-up.

02

Conditions studied

  • Digital Health Literacy
  • Information Security Awareness

Browse trials for

Keywords

  • Cyber Health Education
  • Digital Health Literacy
  • Information Security Awareness
  • High School Students
  • Adolescents
  • Interactive Education
  • Demonstration-Based Education
03

In context

Literacy

201 studies on the registry are indexed under Literacy; 69 are open to participants now.

This study's enrollment of 113 is close to the median of 124 across 170 interventional studies indexed under Literacy.

Browse Literacy studies →

Lead sponsor

This is the only study on the registry with Zeynep Yaztürk as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 19 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being enrolled as a 10th- or 11th-grade student at one of the high schools included in the study.
  • Being within the specified age range.
  • Volunteering to participate in the study.
  • Providing informed assent to participate in the study.
  • Providing written from a parent or legal guardian.
  • Being able to complete the study questionnaires and participate in the educational sessions.

Exclusion criteria

Exclusion Criteria:

  • Not providing student assent or parental/legal guardian consent.
  • Having a condition that prevents participation in the educational sessions or completion of the data collection forms.
  • Being absent during the baseline assessment or educational intervention.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
113 participants (actual)

Study arms

  • Experimental
    Interactive Cyber Health Education Group

    Students assigned to this arm received a three-week interactive and demonstration-based cyber health education program, consisting of one 30-40-minute session per week. The program included interactive presentations, demonstrations, scenario-based activities, group discussions, and question-and-answer sessions focusing on digital health literacy and information security awareness.

    Behavioral: Interactive Demonstration-Based Cyber Health Education

  • No intervention
    Control Group

    Students assigned to this arm continued their routine school education and did not receive the interactive cyber health education intervention during the study period.

Interventions

  • BehavioralInteractive Demonstration-Based Cyber Health Education

    The intervention consisted of a three-week interactive and demonstration-based cyber health education program delivered to high school students. The program included one 30-40-minute session per week and focused on digital health literacy and information security awareness. Educational methods included interactive presentations, demonstrations, scenario-based activities, group discussions, and question-and-answer sessions.

06

What researchers measure

Primary outcomes

  1. Change in Digital Health Literacy

    Digital health literacy will be assessed using the Turkish version of the eHealth Literacy Scale (eHEALS). The scale consists of 8 scored items rated on a 5-point Likert scale, yielding a total score ranging from 8 to 40. Higher scores indicate higher levels of eHealth literacy. Changes in total scores will be evaluated across the study assessment points.

    Time frame: Baseline, immediately after the 3-week intervention, and 4 weeks after the intervention

Secondary outcomes

  1. Change in Information Security Awareness

    Information security awareness was assessed using the Information Security Awareness Scale. The scale assesses students' awareness of information security and safe digital behaviors. Changes in total scores were evaluated across the study assessment points, with higher scores indicating greater information security awareness.

    Time frame: Baseline, immediately after the 3-week intervention, and 4 weeks after the intervention

07

Study locations

1 site
  • Çankaya Anadolu Lisesi
    Ankara, Çankaya 06670, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared due to ethical and confidentiality considerations and the absence of participant consent for data sharing.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2026 to primary completion in Jun 2026, 1 month.

Of 115 non-industry interventional studies with no phase under Literacy, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 20. This study's 1 month is below that.

Counting every sponsor, half of 117 studies reached it within 11 months; a quarter within 4 and three quarters within 19.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 11, 2026
First posted
Aug 14, 2026
StartActual
Apr 21, 2026
Primary completionActual
Jun 2, 2026
CompletionActual
Jun 2, 2026
Last update
Aug 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07765641
Lead sponsor
Zeynep Yaztürk
Responsible party
Zeynep Yaztürk (Assistant Professor, Yuksek Ihtisas University) — Sponsor-investigator
First posted
Aug 14, 2026
Start date
Apr 21, 2026
Primary completion
Jun 2, 2026
Completion
Jun 2, 2026
Last update
Aug 20, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion